West Syndrome
8
4
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
A Study to Prevent Infantile Spasms Relapse
Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome
Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation
Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm
Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)
Molecular Genetics in Infantile Spasms
Prednisolone in Infantile Spasms- High Dose Versus Usual Dose